Seeking Alpha

GREENBROOK TMS ANNOUNCES ACCEPTANCE OF ITS MANAGEMENT CEASE TRADE ORDER APPLICATION

TORONTO, April 6, 2023 /PRNewswire/ - Greenbrook TMS Inc. (GBNH) ("Greenbrook" or the "Company") announced today that the Ontario Securities Commission (the "OSC"), the Company's principal regulator ...
Seeking Alpha

GREENBROOK TMS DRAWS AN ADDITIONAL US$2.75 MILLION IN DEBT FINANCING

TORONTO, Feb. 7, 2023 /PRNewswire/ - Greenbrook TMS Inc. (GTMS:CA) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it has received an aggregate of US$2.75 million in debt ...
Nasdaq

Greenbrook TMS: Acquisition and Strategic Financial Moves

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Greenbrook Tms ( (GBNHF)) has ...
Nasdaq

GREENBROOK TMS CONFIRMS RESIGNATION OF DIRECTOR

Operating through 133 Company-operated treatment centers, Greenbrook is a leading provider of TMS and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major ...
Business Insider

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

TORONTO, Dec. 15, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-first amendment (the "Amendment") to the ...
Business Insider

Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement

Operating through 130 company-operated treatment centers, Greenbrook TMS is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy and Spravato ® (esketamine nasal spray), FDA-cleared ...
Business Wire

Greenbrook TMS to Acquire Achieve TMS East and Central and Announces US$10 Million Bought Deal Public Offering

Achieve TMS East/Central has an experienced regional management and operations team and robust infrastructure. Anticipated post-acquisition synergies with Greenbrook’s established shared services ...
abc27

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today ...
abc27

GREENBROOK TMS REPORTS FISCAL YEAR 2023 OPERATIONAL AND FINANCIAL RESULTS

Operating through 130 Company-operated treatment centers, Greenbrook is a leading provider of TMS and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major ...
AOL

Greenbrook TMS Inc.'s (TSE:GTMS): Chief Executive Officer Benjamin Klein is the most bullish insider, and their stock value gained 11% last week

Every investor in Greenbrook TMS Inc. (TSE:GTMS) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual insiders with 43% ...
Business Wire

Greenbrook TMS Announces Closing of Success TMS Acquisition and US$75 Million Credit Facility With Madryn Asset Management

The Company believes the Acquisition of Success TMS’ 47 TMS centers in the states of Florida, Pennsylvania, Illinois, New Jersey, Nevada and Wisconsin is highly complementary to Greenbrook’s existing ...
Psychology Today

Greenbrook TMS NeuroHealth Centers Missouri

Greenbrook TMS of Missouri offers compassionate care to thousands needing mental health support. We provide TMS, esketamine nasal spray, talk therapy, and medication management. Taking the first step ...